Friday, 12 March 2010

Past Partners & Sponsors

The level of partnership is determined by the amount of core funding, financial support for individual projects and resources provided. This level can change throughout the year should project involvement be increased.


2009

  • Solvay
DIAMOND PARTNER
  • GlaxoSmithKline PLATINUM PARTNER
  • Medtronic
GOLD PARTNER
  • Boehringer Ingelheim
GOLD PARTNER
  • GE Healthcare
GOLD PARTNER
  • H Lundbeck
GOLD PARTNER
  • Teva Pharmaceuticals
GOLD PARTNER
  • Norgine SILVER PARTNER
  • Merck Serono
SILVER PARTNER
  • UCB
SILVER PARTNER

 

Top of page

2008

  • Solvay
DIAMOND PARTNER
  • Britannia Pharmaceuticals
PLATINUM PARTNER
  • GlaxoSmithKline
PLATINUM PARTNER
  • Boehringer Ingelheim
GOLD PARTNER
  • Medtronic
GOLD PARTNER
  • Merck Serono
GOLD PARTNER
  • H Lundbeck
SILVER PARTNER
  • Novartis A/G
SILVER PARTNER
  • Orion
SILVER PARTNER
  • Teva Pharmaceuticals
SILVER PARTNER
  • Norgine
BRONZE PARTNER
  • F. Hoffmann-La Roche Ltd.
BRONZE PARTNER
  • Valeant Pharmaceuticals
BRONZE PARTNER
Diamond Platinum Gold SILVER Bronze
Solvay Pharmaceuticals
€ 40,000 *
Britannia
€6,700 *
Boehringer Ingelheim
€ 20,000 *
Lundbeck and TEVA
€ 10,000 *
Norgine
€7,500 *
€ 110,000 ** €26,130 ** ** ** **
  GlaxoSmithKline
€ 30,000 *
Medtronic
€ 21,000 *
Novartis and Orion
€14,280 *
F. Hoffmann -La Roche Ltd.
€6,520 *
  ** € 8,000 ** ** **
        Valeant Phamaceuticals
€5,000 *
        **

* Core funding
** Work Programme funding

 

Top of page

2007

  • Britannia Pharmaceuticals
PLATINUM PARTNER
  • GE Healthcare
PLATINUM PARTNER
  • GlaxoSmithKline
PLATINUM PARTNER
  • Medtronic
PLATINUM PARTNER
  • Novartis A/G
PLATINUM PARTNER
  • Orion Pharma
PLATINUM PARTNER
  • Solvay
PLATINUM PARTNER
  • F. Hoffmann-La Roche Ltd. - GOLD PARTNER
  • Boehringer Ingelheim
SILVER PARTNER
  • H Lundbeck
SILVER PARTNER
  • Norgine SILVER PARTNER
  • Schwarz Pharma
SILVER PARTNER
  • Teva Pharmaceuticals
SILVER PARTNER
  • Valeant Pharmaceuticals
SILVER PARTNER
Platinum Gold Silver
Britannia Pharmaceuticals
€7,500
F. Hoffmann-La Roche Ltd.
€15,888
Boehringer Ingleheim
€7,500
GE Healthcare
€27,350
  H Lundbeck
€5,000
GlaxoSmithKline
€39,800
  Norgine
€7,500
Medtronic
€16,000
  Schwarz Pharma
€6,000
Novartis A/G
€12,500
  Teva Pharmaceuticals
€5,000
Orion Pharma
€12,500
  Valeant Pharmaceuticals
€7,000
Solvay Pharmaceuticals
€20,000
   

 

Top of page

2006

  • Britannia Paharmaceuticals Ltd
  • GE Healthcare
  • GlaxoSmithKline
  • Medtronic
  • Novartis
  • Orion Pharma
  • H. Lundbeck A/S
  • Solvay
  • Teva
  • F. Hoffmann-La Roche Ltd.
  • Norgine
  • Schwarz Pharma
  • Valeant Pharma
Committed Core Funding
Platinum Gold Silver
Britannia Pharmaceuticals
£5,000
H. Lundbeck A/S
€ 10,000
F Hoffman- La Roche Ltd
CHF 9,625
GE Healthcare
£20,000
Solvay Pharmaceuticals
€17,000
Norgine
£5,282.50
GlaxoSmithKline
£17,606
Teva Pharmaceuticals
€ 10,000
Schwarz Pharma
€5,000
Medtronic
€15,000
  Valeant Pharma
$ 10,000
Novartis
CHF 10,000
   
Orion Pharma
CHF 10,000
   

 

Top of page

2005

  • GE Healthcare
  • GlaxoSmithKline
  • Movers & Shakers
  • Orion Pharma
  • Novartis
  • Valeant Pharma
  • H. Lundbeck A/S
  • F. Hoffmann-La Roche Ltd.
  • Teva
  • Britannia Paharmaceuticals Ltd
  • Medtronic
  • neoPharma
  • Norgine

Other Supporters

  • Boehringer Ingelheim
  • Clonmel Healthcare
  • Medtronic Foundation
  • Provalis
  • Schwarz Pharma
  • Solvay
Committed Core Funding
Platinum Gold Silver
GE Healthcare
£20,000
F Hoffman- La Roche Ltd
CHF 9,625
Britannia Pharmaceuticals
£4,000
GlaxoSmithKline
£17,385
H. Lundbeck A/S
€ 10,000
Medtronic
€7,500
Novartis
CHF 10,000
Teva Pharmaceuticals
€ 10,000
Norgine
€7,500
Orion Pharma
CHF 10,000
  Neopharma
€7,500
Valeant Pharma
$ 30,000
   

 

Top of page

2004

  • GE Healthcare
  • Novartis
  • Orion Pharma
  • Pfizer
  • F. Hoffmann-La Roche Ltd.

Other Supporters

  • Britannia Paharmaceuticals Ltd
  • Boehringer Ingelheim
  • GlaxoSmithKline
  • H. Lundbeck A/S
  • Medtronic
  • Medtronic Foundation
  • Norgine
  • Roche
  • Teva